New and Practical Synthesis of Montelukast Sodium, an Antiasthmatic Drug

REFERENCES

• Belly , M. L. ; Leger , S. ; Labelle , M. ; Roy , P. ; Xiang , Y. B. ; Guay , D. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists. US Patent 5,565,473, 1996.
   Google Scholar
• Bhupathy , M. ; McNamara , J. M. ; Sidler , D. R. ; Volante , R. P. ; Bergan , J. Process for the preparation of leukotriene antagonists. US Patent 5,614,632, 1997; WO 9518107, 1995.
   Google Scholar
• Belley , M. L. ; Leger , S. ; Roy , P. ; Xiang , Y. B. ; Labelle , M. ; Guay , D. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists. EP Patent 408,717 B1, 1998.
   Google Scholar
• Halama , A. ; Jirman , J. ; Bouskova , O. ; Gibala , P. ; Jarrah , K. Improved process for the preparation of montelukast: Development of an efficient synthesis, identification of critical impurities and degradants . Org. Process Res. Dev. 2010 , 14 ( 2 ), 425 – 431 .
   Web of Science ®Google Scholar
• Labelle , M. ; Belley , M. ; Gareau , Y. ; Gauthier , J. Y. ; Guay , D. ; Gordon , R. ; Grossman , S. G. ; Jones , T. R. ; Leblanc , Y. ; McAuliffe , M. ; McFarlane , C. ; Masson , P. ; Metters , K. M. ; Ouimet , N. ; Patrick , D. H. ; Piechuta , H. ; Rochette , C. ; Sawyer , N. ; Xiang , Y. B. ; Pickett , C. B. ; Ford-Hutchinson , A. W. ; Zamboni , R. J. ; Young , R. N. Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enzyme induction. Bioorg. Med. Chem. Lett. 1995, 5(3), 283–288.
   Web of Science ®Google Scholar
• Schoors , D. F. ; Smet , M. D. ; Reiss , T. ; Margolskee , D. ; Cheng , H. ; Larson , P. ; Amin , R. ; Somers , G. Single dose pharmacokinetics, safety, and tolerability of MK-0476, a new leukotriene D4-receptor antagonists, in healthy volunteers . Br. J. Clin. Pharmacol. 1995 , 40 , 277 – 280 .
   PubMed Web of Science ®Google Scholar
• (a) Jordi , B. B. ; Llorenc , R. J. ; Mireia , P. A. ; Xavier , V. E. ; Esther , G. C. Process for preparing a leukotriene antagonist. PCT application WO 2007/101841 A2, 2007 ; (b) King , S. ; Pipik , B. ; Colon , D. A. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid. US Patent 5,523,477, 1996.
   Google Scholar
• (a) Graul , A. ; Martin , L. ; Castaner , J. Montelukast sodium . Drugs Fut. 1997 , 22 ( 10 ), 1103 . (b) Danvor , K. ; Vensa , K. ; Renata , O. A new process for the preparation of montelukast. PCT application WO 2008/049922 A2, 2008.
   Google Scholar
• Satyanarayana , B. ; Pratap Reddy , P. New and improved synthesis of montelukast, an anti-asthmatic drug . Synth. Commun. 2007 , 37 ( 4 ), 545 – 549 .
   Web of Science ®Google Scholar
• Larsen , R. D. ; Corley , E. G. ; King , A. O. ; Carroll , J. D. ; Davis , P. ; Verhoeven , T. R. ; Reider , P. J. ; Labelle , M. ; Gauthier , J. Y. ; Xiang , Y. B. ; Zamboni , R. J. Practical route to a new class of LTD4 receptor antagonists . J. Org. Chem. 1996 , 61 , 3398 – 3405 .
   Web of Science ®Google Scholar
• (a) Biniecki , S. ; Rylski , L. Synthesis of 1-hydrazino-6-chlorophthalazine and 1-hydrazino-7-chlorophthalazine . Ann. Pharm. Fr. 1958 , 16 , 21 – 26 [in French]; (b) A shorter approach could be the selective reduction of chlorophthalic anhydride; no success was obtained with this procedure. For an example of this method, see Taub , D. ; Girotra , N. N. ; Hoffsommer , R. D. ; Kuo , C. H. ; Slates , H. L. Tetrahedron 1968 , 24 , 2443 – 2461 .
   PubMedGoogle Scholar
• (a) Ojima , I. ; Kogure , T. Reduction of carbonyl compounds via hydrosilylation, 4: Highly regioselective reductions of α,β-unsaturated carbonyl compounds . Organometallics 1982 , 1 , 1390 – 1399 ; (b) Malek , J. Reduction by metal alkoxyaluminium hydrides . Org. React. 1985 , 34 , 1 .
   Web of Science ®Google Scholar
• Scott , I. L. ; Kuksa , V. A. ; Gall , A. ; Orme , M. W. ; Gage , J. ; Little , T. L. Jr. ; Jiang , Q. ; Rossiter , L. M. ; Mcgee , K. ; Kubota , R. Styrenyl derivative compounds for treating ophthalmic diseases and disorders. PCT application WO 2009/058216, 2009.
   Google Scholar
• King , A. O. ; Corley , E. G. ; Anderson , R. K. ; Larsen , R. D. ; Verhoeven , T. R. ; Reider , P. J. ; Xiang , Y. B. ; Belly , M. ; Leblanc , Y. ; Labelle , M. ; Prasit , P. ; Zamboni , R. J. An efficient synthesis of LTD4 antagonist L-699,392 . J. Org. Chem. 1993 , 58 , 3731 – 3735 .
   Web of Science ®Google Scholar
• (a) Heck , R. G. Palladium Reagents in Organic Syntheses ; Academic Press : San Diego , 1985 . (b) Heck , R. F. Vinyl substitutions with organopalladium intermediates . In Comprehensive Organic Synthesis ; B. M. Trost , (Ed.); Pergamon Press : New York , 1991 ; vol. 4 , Chapter 3 , p. 833 ; (c) Melpolder , J. B. ; Heck , R. F. Palladium-catalyzed arylation of allylic alcohols with aryl halides. J. Org. Chem. 1976, 41, 265–272 ; (d) Chalk , A. J. ; Magennis , S. A. Palladium-catalyzed vinyl substitution reactions, II: Synthesis of aryl substituted allylic alcohols, aldehydes, and ketones from aryl halides and unsaturated alcohols. J. Org. Chem. 1976, 41, 1206–1209 ; (e) Jeffery , T. Palladium-catalysed arylation of allylic alcohols: Highly selective synthesis of β-aromatic carbonyl compounds or β-aromatic α, β-unsaturated alcohols. Tetrahedron Lett. 1991, 32(19), 2121–2124 .
   Google Scholar
• (a) Kim , J. ; Suri , J. T. ; Cordes , D. B. ; Singaram , B. Asymmetric reductions involving borohydrides: A practical asymmetric reduction of ketones mediated by (L)-TarB-NO2: A chiral Lewis acid. Org. Process Res. Dev. 2006, 10(5), 949–958; (b) Cordes , D. B. ; Kwong , T. J. ; Morgan , K. A. ; Singaram , B. Chiral styrene oxides from α-haloacetophenones using NaBH4 and TarB-NO2: A chiral Lewis acid. Tetrahedron Lett. 2006, 47(3), 349–351; (c) Suri , J. T. ; Vu , T. ; Hernandez , A. ; Congdon , J. ; Singaram , B. Enantioselective reduction of aryl ketones using LiBH4 and TarB-X: A chiral Lewis acid. Tetrahedron Lett. 2002, 43, 3649–3652; (d) Corey , E. J. ; Bakshi , R. K. ; Shibata , S. Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines: Mechanism and synthetic implications. J. Am. Chem. Soc. 1987, 109, 5551–5553; (e) Corey , E. J. ; Bakshi , R. K. ; Shibata , S. Chen , C. P. ; Singh , V. K. A stable and easily prepared catalyst for the enantioselective reduction of ketones: Applications to multistep syntheses. J. Am. Chem. Soc. 1987, 109, 7925–7926; (f) Mathre , D. J. ; Jones , T. K. ; Xavier , L. C. ; Blacklock , T. J. ; Reamer , R. A. ; Mohan , J. J. ; Jones , T. E. T. ; Hoogsteen , K. ; Baum , M. W. ; Grabowshi , E. J. J. A practical enantioselective synthesis of α,α-diaryl-2-pyrrolidinemethanol: Preparation and chemistry of the corresponding oxazaborolidines. J. Org. Chem. 1991, 56, 751–762; (g) Liang , J. ; Lalonde , J. ; Borup , B. ; Mitchell , V. ; Mundorff , E. ; Trinh , N. ; Kochrekar , D. A. ; Cherat , R. N. ; Pai , G. G. Development of a biocatalytic process as an alternative to the (−)-DIP-Cl-mediated asymmetric reduction of a key intermediate of montelukast. Org. Process Res. Dev. 2010, 14, 193–198.
   Web of Science ®Google Scholar
• (a) Caspi , D. D. ; Ebner , D. C. ; Bagdanoff , J. T. Stoltz , B. M. The resolution of important pharmaceutical building blocks by palladium-catalysed aerobic oxidation of secondary alcohol . Adv. Synth. Catal. 2004 , 346 ( 2–3 ), 185 – 189 ; (b) Andres , J. A. P. ; Clotet , J. H. ; Barjoan , P. D. Process for obtaining montelukast. US Patent Application US 2008/0194825 A1, 2008.
   Web of Science ®Google Scholar
• Kagan , E. S. ; Andashev , B. I. Synthesis of vinyl derivatives of quinoline by Mannich reaction . Chem. Abstr. 1968 , 68 , 114408 .
   Google Scholar
• Apodaca , R. ; Breitenbucher , J. G. ; Chambers , A. L. ; Seierstad , M. ; Xiao , W. Oxazolyl piperidine modulators of fatty acid amide hydrolase. PCT Application WO 2007/140005 A2, 2007.
   Google Scholar
• Venkataraman , S. ; Srinivasan , T. R. ; Chandra Sekhar , B. V. V. N. ; Alokkumar , S. ; Ravi Kumar , K. ; Sanjeev Kumar , A. Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl] cyclopropaneacetic acid (montelukast) and its pharmaceutically acceptable salts. US Patent 7,189,853 B2, 2007.
   Google Scholar